Results 1 to 10 of about 41,565 (267)

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2023
Background Differences in pain between subtypes of multiple sclerosis are understudied. Objective To compare the prevalence of pain, and the association between pain and: (a) pain interference and (b) social participation in people with relapsing ...
Dhruv Jain, Charles N Bernstein, Lesley A Graff, Scott B Patten, James M Bolton, John D Fisk, Carol Hitchon, James J Marriott, Ruth Ann Marrie,   +9 more
doaj   +1 more source

Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis [PDF]

Arquivos de Neuro-Psiquiatria, 2016
Sleep disorders in patients with multiple sclerosis have various causes and interfere with daytime wakefulness. This study assessed the correlation between fatigue, excessive daytime sleepiness and level of disability.
Douglas Martins Braga, Gilmar Fernandes do Prado, Denis Bernardi Bichueti, Enedina Maria Lobato de Oliveira   +3 more
doaj   +4 more sources

Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients. [PDF]

PLoS ONE, 2012
Interferon-β is a first-line therapy used to prevent relapses in relapsing-remitting multiple sclerosis. The clinical benefit of interferon-β in relapsing-remitting multiple sclerosis is attributed to its immunomodulatory effects on inflammatory ...
Nicolas Molnarfi, Mahdia Benkhoucha, Kristbjörg Bjarnadóttir, Catherine Juillard, Patrice H Lalive   +4 more
doaj   +1 more source

Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis

Frontiers in Immunology, 2023
ObjectivesRecent studies supported coagulation involvement in multiple sclerosis, an inflammatory-demyelinating and degenerative disease of the central nervous system. The main objectives of this observational study were to identify the most specific pro-
Tatiana Koudriavtseva, Tatiana Koudriavtseva, Svetlana Lorenzano, Maria Cellerino, Maria Cellerino, Mauro Truglio, Marco Fiorelli, Caterina Lapucci, Giovanna D’Agosto, Laura Conti, Annunziata Stefanile, Silvana Zannino, Maria Maddalena Filippi, Antonio Cortese, Carlo Piantadosi, Marta Maschio, Andrea Maialetti, Edvina Galiè, Marco Salvetti, Marco Salvetti, Matilde Inglese, Matilde Inglese   +21 more
doaj   +1 more source

Role of Diet and Supplementation with Omega-3 Polyunsaturated Fatty Acids for Managing Chronic Fatigue in Patients with Relapsing-Remitting Multiple Sclerosis [PDF]

Journal of Biomedical & Clinical Research, 2022
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS) with unclear and multifactorial etiology, variable clinical symptoms with different severity, and treatment with limited efficacy.
Nicholas Shepherd, Emiliya Ovcharova, Maya Danovska, Diana Marinova, Diana Pendicheva, Pencho Tonchev   +5 more
doaj   +3 more sources

Meta‐analysis of the use of Ofatumumab in the treatment of relapsing‐remitting multiple sclerosis

Medicine Advances, 2023
Background Ofatumumab is the first monoclonal antibody developed specifically for treating relapsed multiple sclerosis (RMS). This disease (Multiple Sclerosis) includes relapsing–remitting multiple sclerosis (RRMS), a chronic autoimmune illness that ...
Peter Olujimi Odutola, Peter Oluwatobi Olorunyomi, Olanrewaju Olamide Olatawura, Ifeoluwapo Olorunyomi, Olukayode Oluyinka Madojutimi, Uju Okeke, Ayomide O. Fatunsin, Victoria Eneh   +7 more
doaj   +1 more source

Sensorimotor function in progressive multiple sclerosis

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2020
Background A sensitive test reflecting subtle sensorimotor changes throughout disease progression independent of mobility impairment is currently lacking in progressive multiple sclerosis. Objectives We examined non-ambulatory measures of upper and lower
Jules D Miehm, John Buonaccorsi, Jongil Lim, Sumire Sato, Caitlin Rajala, Julianna Averill, Farnaz Khalighinejad, Carolina Ionete, Stephanie L Jones, Jane A Kent, Richard EA van Emmerik   +10 more
doaj   +1 more source

Primary progressive multiple sclerosis in the Polish population

Aktualności Neurologiczne, 2017
Objectives: The aim of the study was the epidemiological analysis and evaluation of selected clinical and sociodemographic factors in Polish patients with primary progressive multiple sclerosis.
Waldemar Brola, Piotr Sobolewski, Stanisław Flaga, Małgorzata Fudala, Andrzej Potemkowski   +4 more
doaj   +1 more source

Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis. [PDF]

PLoS ONE, 2016
Conduction along the optic nerve is often slowed in multiple sclerosis (MS). This is typically assessed by measuring the latency of the P100 component of the Visual Evoked Potential (VEP) using electroencephalography.
Hanni S M Kiiski, Sinéad Ní Riada, Edmund C Lalor, Nuno R Gonçalves, Hugh Nolan, Robert Whelan, Róisín Lonergan, Siobhán Kelly, Marie Claire O'Brien, Katie Kinsella, Jessica Bramham, Teresa Burke, Seán Ó Donnchadha, Michael Hutchinson, Niall Tubridy, Richard B Reilly   +15 more
doaj   +1 more source

EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN

Вопросы современной педиатрии, 2013
Aim: to evaluate the impact of subcutaneous interferon β-1a on matrix metalloproteinases 3, 8, 9 (MMP), cytokines (tumor necrosis factor α — TNF α, and transforming growth factor β1 — TGF β1) levels in serum of children with relapsing-remitting multiple ...
L. M. Kuzenkova, L. A. Pak, V.M. Studenikin, N. N. Shatilova, B. I. Bursagova, I. E. Smirnova   +5 more
doaj   +1 more source